We are live on ! Find out more
RXDX

Ignyta, Inc.
RXDX

Delisted

RXDX was delisted on the 7th of February, 2018.

120 hedge funds and large institutions have $597M invested in Ignyta, Inc. in 2017 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 50 increasing their positions, 19 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 19

133% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 15

27% more capital invested

Capital invested by funds: $471M → $597M (+$126M)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

19% more funds holding

Funds holding: 101120 (+19)

5.04% more ownership

Funds ownership: 80.88%85.92% (+5%)

Holders
120
Holders Change
+19
Holders Change %
+18.81%
% of All Funds
2.98%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
35
Increased
50
Reduced
19
Closed
15
Calls
$470K
Puts
Net Calls
+$470K
Net Calls Change
+$291K

RXDX Hedge Fund Activity: Q3 2017 in Review

120 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Ignyta, Inc. (RXDX) for Q3 2017, worth a combined $597M — up 27% from $471M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new RXDX positions and 15 closed out — a net gain of 20 holders — while 50 added to existing stakes and 19 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $20.6M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $18.8M sold.

  • 120 institutional investors held Ignyta, Inc. (RXDX) as of Q3 2017, up from 101 in Q2 2017.
  • Funds reported $597M of Ignyta, Inc. stock for Q3 2017, up 27% quarter-over-quarter.
  • 35 funds opened new Ignyta, Inc. positions in Q3 2017 and 15 closed out, a net change of +20 holders.
  • The largest Ignyta, Inc. buyer in Q3 2017 was Cormorant Asset Management, an estimated $20.6M added.
  • The largest Ignyta, Inc. seller in Q3 2017 was PFM Health Sciences, an estimated $18.8M sold.

Based on aggregated 13F filings for Q3 2017.